Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.93 USD | +6.62% | +5.96% | +17.86% |
02-27 | North American Morning Briefing : Stock Futures -2- | DJ |
02-26 | Citigroup Adjusts Price Target on Cogent Biosciences to $13 From $11, Maintains Buy Rating | MT |
Sales 2024 * | - | Sales 2025 * | 1.33M 1.82M | Capitalization | 663M 909M |
---|---|---|---|---|---|
Net income 2024 * | -220M -302M | Net income 2025 * | -232M -318M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 500 x |
P/E ratio 2024 * |
-3.46
x | P/E ratio 2025 * |
-3.48
x | Employees | 164 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.68% |
Latest transcript on Cogent Biosciences, Inc.
1 day | +6.62% | ||
1 week | +5.96% | ||
Current month | +6.62% | ||
1 month | +0.43% | ||
3 months | +54.69% | ||
6 months | -15.38% | ||
Current year | +17.86% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Robbins
CEO | Chief Executive Officer | 48 | 20-10-22 |
John Green
DFI | Director of Finance/CFO | 43 | 18-05-31 |
Rachael Easton
CTO | Chief Tech/Sci/R&D Officer | - | 22-11-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 72 | 19-07-25 |
Matthew Ros
BRD | Director/Board Member | 57 | 19-07-25 |
Todd Shegog
BRD | Director/Board Member | 59 | 21-02-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 237 M€ | +0.96% | - | |
0.04% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 6.93 | +6.62% | 2,649,834 |
24-04-30 | 6.5 | -3.13% | 1,574,166 |
24-04-29 | 6.71 | +11.46% | 1,892,528 |
24-04-26 | 6.02 | +0.17% | 912,165 |
24-04-25 | 6.01 | -8.10% | 1,212,019 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.86% | 663M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+3.87% | 22.25B | |
-14.77% | 21.68B | |
-8.98% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- COGT Stock